title: Expression and activity profiles of DPP IV/CD26 and NEP/CD10 glycoproteins in the human renal cancer are tumor-type dependent.
abstract: BACKGROUND
  Cell-surface glycoproteins play critical roles in cell-to-cell recognition, signal transduction and regulation, thus being crucial in cell proliferation and cancer etiogenesis and development. DPP IV and NEP are ubiquitous glycopeptidases closely linked to tumor pathogenesis and development, and they are used as markers in some cancers. In the present study, the activity and protein and mRNA expression of these glycoproteins were analysed in a subset of clear-cell (CCRCC) and chromophobe (ChRCC) renal cell carcinomas, and in renal oncocytomas (RO).
  
  
  METHODS
  Peptidase activities were measured by conventional enzymatic assays with fluorogen-derived substrates. Gene expression was quantitatively determined by qRT-PCR and membrane-bound protein expression and distribution analysis was performed by specific immunostaining.
  
  
  RESULTS
  The activity of both glycoproteins was sharply decreased in the three histological types of renal tumors. Protein and mRNA expression was strongly downregulated in tumors from distal nephron (ChRCC and RO). Moreover, soluble DPP IV activity positively correlated with the aggressiveness of CCRCCs (higher activities in high grade tumors).
  
  
  CONCLUSIONS
  These results support the pivotal role for DPP IV and NEP in the malignant transformation pathways and point to these peptidases as potential diagnostic markers.
authors.affiliation: Department of Physiology, Faculty of Medicine and Dentistry, University of Basque Country, Barrio Sarriena s/n, 48940-Leioa, Spain.
authors.forename: Adolfo
authors.initials: A
authors.lastname: Varona
authors.forename: Lorena
authors.initials: L
authors.lastname: Blanco
authors.forename: Itxaro
authors.initials: I
authors.lastname: Perez
authors.forename: Javier
authors.initials: J
authors.lastname: Gil
authors.forename: Jon
authors.initials: J
authors.lastname: Irazusta
authors.forename: José I
authors.initials: JI
authors.lastname: López
authors.forename: M Luz
authors.initials: ML
authors.lastname: Candenas
authors.forename: Francisco M
authors.initials: FM
authors.lastname: Pinto
authors.forename: Gorka
authors.initials: G
authors.lastname: Larrinaga
mesh_terms: D018249:Adenoma, Oxyphilic / Q000201:enzymology* / Q000235:genetics / Q000473:pathology; D000368:Aged; D014408:Biomarkers, Tumor / Q000032:analysis* / Q000235:genetics; D002292:Carcinoma, Renal Cell / Q000201:enzymology* / Q000235:genetics / Q000473:pathology; D018819:Dipeptidyl Peptidase 4 / Q000032:analysis* / Q000235:genetics; D005260:Female; D015971:Gene Expression Regulation, Enzymologic; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D007150:Immunohistochemistry; D007680:Kidney Neoplasms / Q000201:enzymology* / Q000235:genetics / Q000473:pathology; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D015260:Neprilysin / Q000032:analysis* / Q000235:genetics; D012333:RNA, Messenger / Q000032:analysis; D020133:Reverse Transcriptase Polymerase Chain Reaction
chemical_list: D014408:Biomarkers, Tumor; D012333:RNA, Messenger; C042807:DPP4 protein, human; D018819:Dipeptidyl Peptidase 4; D015260:Neprilysin
references.citation: Methods Mol Biol. 2000;132:365-86
references.pmid: 10547847
references.citation: Biochim Biophys Acta. 2005 Aug 1;1751(1):45-51
references.pmid: 16054016
references.citation: Regul Pept. 2007 Dec 4;144(1-3):56-61
references.pmid: 17692401
references.citation: Eur Urol. 2006 May;49(5):798-805
references.pmid: 16442207
references.citation: Am J Surg Pathol. 1982 Oct;6(7):655-63
references.pmid: 7180965
references.citation: Am J Pathol. 1990 Oct;137(4):895-905
references.pmid: 1699423
references.citation: Endocrinology. 1995 Feb;136(2):779-87
references.pmid: 7835310
references.citation: Br J Pharmacol. 2003 Jun;139(3):523-32
references.pmid: 12788812
references.citation: Int J Urol. 2006 May;13(5):573-80
references.pmid: 16771728
references.citation: Biochim Biophys Acta. 2005 Aug 1;1751(1):52-9
references.pmid: 16054017
references.citation: CA Cancer J Clin. 2007 Jan-Feb;57(1):43-66
references.pmid: 17237035
references.citation: Genome Biol. 2002 Jun 18;3(7):RESEARCH0034
references.pmid: 12184808
references.citation: Mod Pathol. 2004 Dec;17(12):1455-63
references.pmid: 15286660
references.citation: J Biol Chem. 2006 Nov 3;281(44):33597-605
references.pmid: 16940054
references.citation: Nat Med. 1998 Jan;4(1):50-7
references.pmid: 9427606
references.citation: Clin Lab Med. 2005 Jun;25(2):247-57
references.pmid: 15848735
references.citation: Int J Mol Med. 1998 Oct;2(4):409-14
references.pmid: 9857225
references.citation: Am J Surg Pathol. 2000 Feb;24(2):203-10
references.pmid: 10680888
references.citation: Angew Chem Int Ed Engl. 2005 Jun 27;44(26):4058-61
references.pmid: 15926197
references.citation: Br J Cancer. 2000 Nov;83(9):1139-46
references.pmid: 11027426
references.citation: Am J Physiol Renal Physiol. 2007 Feb;292(2):F780-8
references.pmid: 16985214
references.citation: Eur J Pharmacol. 2004 Jun 28;494(2-3):233-9
references.pmid: 15212980
references.citation: J Biol Chem. 1995 Jun 9;270(23):14107-14
references.pmid: 7539799
references.citation: Tumour Biol. 2006;27(1):1-7
references.pmid: 16340244
references.citation: Clin Cancer Res. 2006 Jun 1;12(11 Pt 1):3470-7
references.pmid: 16740772
references.citation: Histol Histopathol. 2006 Dec;21(12):1339-53
references.pmid: 16977585
references.citation: Am J Physiol Renal Physiol. 2008 Apr;294(4):F850-8
references.pmid: 18216146
references.citation: Anal Biochem. 1984 Aug 15;141(1):62-9
references.pmid: 6388410
references.citation: Biochem Pharmacol. 2005 May 15;69(10):1441-50
references.pmid: 15857608
references.citation: Histol Histopathol. 2004 Oct;19(4):1345-51
references.pmid: 15375776
references.citation: BMC Mol Biol. 2007 Jun 08;8:47
references.pmid: 17559644
references.citation: J Cell Biochem. 2007 Nov 1;102(4):878-85
references.pmid: 17786934
references.citation: J Exp Med. 1999 Aug 2;190(3):311-22
references.pmid: 10430620
references.citation: Histopathology. 2004 Nov;45(5):460-7
references.pmid: 15500649
references.citation: Drug Resist Updat. 2005 Feb-Apr;8(1-2):51-8
references.pmid: 15939342
references.citation: Oncogene. 2004 Jan 15;23(2):317-29
references.pmid: 14724562
references.citation: Int J Immunopathol Pharmacol. 2007 Oct-Dec;20(4):697-705
references.pmid: 18179742
references.citation: Biochem Biophys Res Commun. 2004 Jan 23;313(4):856-62
references.pmid: 14706621
references.citation: Int J Biochem Cell Biol. 2004 Mar;36(3):408-21
references.pmid: 14687920
references.citation: Front Biosci. 2008 Jan 01;13:1634-45
references.pmid: 17981655
references.citation: Exp Physiol. 2008 May;93(5):519-27
references.pmid: 18310257